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Leishmaniasis is an infectious disease endemic to
88 countries on 5 continents. It is estimated that there
are 1 to 1.5 million cases of cutaneous leishmaniasis
among local populations, but leishmaniasis also
commonly affects travelers to these endemic
countries. Leishmaniasis is caused by parasitic
protozoa in the genus Leishmania, which are
transmitted by phlebotomine sandflies, and is
divided into 2 categories: Old World and New
World. Old World leishmaniasis is considered mostly
benign and self-limited, whereas NewWorld species
are able to cause a wide array of clinical mani-
festations, from benign to life-threatening disease.
Through dissemination via blood, lymph, and local
extension, NewWorld Leishmania species can cause
mucosal and visceral involvement. Although
mucosal leishmaniasis was originally attributed
exclusively to Leishmania braziliensis, it is now
known that Leishmania panamensis, Leishmania
guyanensis, and Leishmania peruviana, all of the
Viannia subgenuses found in Central and South
America, may also cause mucosal involvement.1-3
Herein, we present an uncommon case of New
World leishmaniasis in 2 travelers returning to the
United States.CASE REPORT
A 49-year-old man and his 17-year-old son
presented for evaluation of ulcerative lesions on
the left leg (father) and right arm (son). The patients
traveled to Costa Rica 3 months prior and noticed
multiple bites on the extremities after returning
home, all of which resolved except for the lesions
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lane.edu.pruritic nor painful, and the patients denied systemic
symptoms. Physical examination of the father’s
left thigh found a 1.5-cm erythematous and indu-
rated nodule with central ulceration (Fig 1, A). There
was a similar 1-cm erythematous, ulcerated and
heme-crusted nodule on the son’s right extensor
arm (Fig 2, A). Biopsies of both lesions found a
superficial and deep mixed inflammatory infiltrate
with overlying ulcerated epidermis. Scattered
microorganisms were present, highlighted by
Giemsa stain (Fig 3, A-C ). Leishmania polymerase
chain reaction (PCR) and DNA sequencing, real-time
PCR, and microscopy confirmed L panamensis. At
2-week follow-up, the father’s lesion had grown in
size and developed small satellite nodules (Fig 1, B).
The father also had a single enlarged lymph node on
the leg near the lesion. The son’s lesion had also
grown slightly, and he had nontender brachial
lymphadenopathy (Fig 2, B). Both patients
continued to deny any new symptoms or systemic
complaints. Given the risk of mucocutaneous
disease, the patients each underwent a 10-day course
of intravenous liposomal amphotericin B therapy.
After treatment, both patients reported that their
lesions had substantially decreased in size. Because L
panamensis is a member of the Leishmania Viannia
subgenus and confers risk of mucocutaneous dis-
ease, oral miltefosine or intravenous pentamidine
are other systemic therapies that could be considered
as future treatments if necessary.JAAD Case Reports 2016;2:95-7.
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Fig 2. A, Ulcer on a 17-year-old man on the right, posterior arm at initial presentation. The site
was previously biopsied. B, The lesion 2 weeks later shows enlargement and additional
exudate.
Fig 1. A, Ulcer on 49-year-old man on the left, anterior leg at initial presentation. B, The lesion
2 weeks later shows significant enlargement, additional exudate, and increased surrounding
induration.
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Members of the Leishmania (Viannia) subgenus
are known to cause destructive lesions of the nasal,
oral, and hypopharyngeal mucosa. Mucosal involve-
ment is rare in travelers and has not been well
studied.3 L panamensis is less well studied than
L braziliensis, but it is thought that mucosal involve-
ment by L panamensis may be less severe. Disease
caused by L panamensis tends to be limited to one
mucosal surface and less destructive with lower rates
of perforation of the nasal septum. The milder
clinical manifestation may be caused by the less
reactogenic nature of L panamensis, that is, lesscapability of the organism to induce a destructive
immune response.1
Treatment of leishmaniasis in travelers remains
controversial. Although evidence exists for treatment
in endemic areas, treatment of leishmaniasis in
travelers is poorly characterized. Because a species-
specific approach may lead to higher cure rates and
lower medication side effects, laboratory tests are
important in identifying causative species. PCR, as
used in this case, offers a highly sensitive means of
identification. Presence of Leishmania may also be
determined by microscopy of tissue smears or by
histopathology of skin biopsy sections. Leishmania
Fig 3. A, Superficial and deep dense dermal infiltrate of lymphocytes, plasma cells, histiocytes,
and epithelioid cells with overlying epidermis. B, Parasitized macrophages. The Leishmania
organisms are round to oval basophilic structures with eccentrically located kinetoplasts. C,
Numerous dermal histiocytes containing cytoplasmic Leishmania parasites. (A and B,
Hematoxylin-eosin stain; C, Giemsa stain.)
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process is difficult and, as demonstrated in this
case, may result in a false-negative result. Local
treatment with topical applications and intralesional
injections may be used in species with little risk of
mucosal involvement; however, for species such as
L panamensis, which are known to affect the
mucosa, systemic therapy is recommended. For
treatment of L panamensis, miltefosine, pentami-
dine, or liposomal amphotericin B, as used in this
case, may be used depending on the clinical picture.
Pentavalent antimonial agents are effective, but less
toxic treatments are preferred.3 We present this caseto highlight this uncommon disease in travelers and
the importance of early recognition and treatment to
avoid mucosal involvement.REFERENCES
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